EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
152 hedge funds and large institutions have $328M invested in Eagle Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $337M → $328M (-$8.86M)
Holders
152
Holding in Top 10
1
Calls
$1.78M
Puts
$15K
Top Buyers
| 1 | +$4.43M | |
| 2 | +$4.38M | |
| 3 | +$2.49M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$1.83M |
| 5 |
HF
HRT Financial
New York
|
+$1.78M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$3.52M | |
| 3 | -$2.33M | |
| 4 |
Millennium Management
New York
|
-$2.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.09M |